North America Blood-based Biomaker For Sports Medicine Market Size & Outlook

The blood-based biomaker for sports medicine market in North America is expected to reach a projected revenue of US$ 511.0 million by 2030. A compound annual growth rate of 8.3% is expected of North America blood-based biomaker for sports medicine market from 2024 to 2030.
Revenue, 2023 (US$M)
$292.5
Forecast, 2030 (US$M)
$511.0
CAGR, 2024 - 2030
8.3%
Report Coverage
North America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America blood-based biomaker for sports medicine market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

North America blood-based biomaker for sports medicine market highlights

  • The North America blood-based biomaker for sports medicine market generated a revenue of USD 292.5 million in 2023.
  • The market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
  • In terms of segment, ck was the largest revenue generating type in 2023.
  • CRP is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 292.5 million
Market revenue in 2030USD 511.0 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentCk
Fastest growing segmentCRP
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6


Other key industry trends

  • In terms of revenue, North America region accounted for 43.9% of the global blood-based biomaker for sports medicine market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 259.9 million by 2030.

Ck was the largest segment with a revenue share of 18.02% in 2023. Horizon Databook has segmented the North America blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.


As athletes and sports organizations increasingly prioritize precise health monitoring, the demand for advanced biomarkers to detect early signs of injuries and optimize recovery is expected to grow. According to a report published by Nature in April 2021, injury rates in professional sports are notably high, with incidents reported at 3.61 per 1,000 athlete exposures in baseball, 19.3 in basketball, 64.7 in football, and 49.4 in ice hockey.

The market benefits from technological advancements in biomarker analysis and a greater emphasis on personalized medicine. With a robust sports culture and a strong healthcare infrastructure, North America leads in integrating these biomarkers into routine athletic care.

In addition, this growth is supported by the need for efficient recovery strategies and enhanced performance monitoring, which are crucial for professional & amateur athletes. As awareness and adoption increase, the market is projected to witness significant growth over the coming decade.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood-based Biomaker for Sports Medicine Market Companies

Name Profile # Employees HQ Website
RayBiotech View profile 101-250 Norcross, Georgia, United States, North America http://www.raybiotech.com/
Randox View profile 1001-5000 Crumlin, Antrim, United Kingdom, Europe http://www.randox.com
Beckman Coulter View profile 10001+ Brea, California, United States, North America http://www.beckmancoulter.com
ARUP Laboratories View profile 1001-5000 Salt Lake City, Utah, United States, North America http://www.aruplab.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

North America blood-based biomaker for sports medicine market size, by country, 2018-2030 (US$M)

North America Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)

North America blood-based biomaker for sports medicine market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online